6 June 2022, London – Global healthcare communications consultancy 90TEN, part of Envision Pharma Group, today announced the promotion of Director Niamh Mangan to the role of Managing Director of 90TEN Medical. Niamh, with the support of her senior leadership team, will be responsible for leading the thriving medical communications side of the agency.
“Niamh has been a key driving force within our medical division, achieving consistent business growth and success within the team for many years. For these reasons, and many more, I’m so pleased Niamh will be stepping into this new role to lead the team,” said Susanne Clark, Global Head, Envision Scientific Solutions.
In addition to Niamh’s promotion, 90TEN are bolstering the senior management team on the 90TEN Communications side of the business, with the promotion of Victoria Dacker to Senior Associate Director and the recent appointment of Harriet Middleton as Senior Associate Director. Victoria joined the team in 2020 and has been fundamental in the 2021 launch of 90TEN US. Joining 90TEN from MSD, Harriet brings over 13 years of both in-house and agency experience in public relations, healthcare communications and policy to the team.
“2022 is shaping up to be a great year for 90TEN and we are delighted to see such inspiring professional development for our existing team members as well as welcoming a new leader to our senior management team,” said Claire Long, Managing Director of 90TEN Communications.
– ends –
About 90TEN
90TEN, part of the Envision Pharma Group, is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and communications. 90TEN provides PR, medical communications, and patient advocacy services that use behavioural science methodologies to maximise brand and health outcomes. 90TEN is one of the leading healthcare communications consultancies in Europe and in 2020 it was named Communications Consultancy of the Year at both the Communiqué Awards and Sabre EMEA Awards. To find out more, visit https://90ten.co.uk/.
About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a global, technology-enabled scientific communications company serving pharmaceutical, biotechnology, and medical device companies. As a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision) that have applicability across many areas of medical affairs and related functional responsibility, Envision provides scientific communication services and technology solutions to more than 90 companies, including 19 of the top 20 pharmaceutical companies. Learn more at: www.envisionpharmagroup.com
For further information, please contact:
Zoe Sycamore
Zoe.sycamore@90ten.co.uk
+44 (0)7921 879 689
